RE:Be careful hereiqw_rocks wrote: https://biologic-med.com/our-objective/
Looks like NSP CEO is on the COVID bandwagon imo. Their partner has to update their website. No mention about any of their current work. Copyright 2016 even!
Hey “iqw_rocks ”,
Maybe you can help me… I am trying to come up with a reason why the NSP CEO shouldn’t be on the COVID bandwagon… and I can’t think of one.
In the last two weeks of NSP & Biologic dealings with Health Canada, NSP has provided several updates – none of which indicate any negativity coming back from Health Canada.
May 21st News release…
Health Canada has performed an initial review of data for a Clinical Trial Application (CTA) and have advised that the Biologic Division within the Health Canada Office of Regulatory Affairs Biologic and Radiopharmaceutical Drugs Directorate is the appropriate channel to which the completed CTA can continue its processing. This significant designation creates a clear path for the CTA to proceed.
May 26th News release…
The Company is pleased to announce that a Clinical Trial Application (CTA) has been submitted to Health Canada for a COVID-19 Phase 2 clinical trial, using Cavaltinib(TM) as the subject test drug. The same study protocol is being prepared for submission to the U.S. FDA regulatory authorities.
June 1st News release…
The Company is now awaiting notification by Health Canada to proceed to the Phase 2 clinical trial stage, by way of a No Objection Letter (NOL). Health Canada reviews all Clinical Trial Applications and notifies the sponsor within 30 calendar days if the application is found to be deficient. At this point NSP is waiting on a response from Health Canada regarding the CTA application.
I recommend that you go back and carefully listen to the whole
Franco Cavalari video interview with Steve Darling. Starting at about the 37 second mark Franco indicates that “…the submission is being reviewed by 2 different departments at Health Canada and that the results/paper that have been submitted…
have really intrigued them…”.
Franco and his company Biologic are the “brains” behind Cavaltinib
TM, the target drug for the Phase 2 clinical trial relating to COVID.
Sure the Biologic website could use an update, but Health Canada isn’t reviewing Biologic’s website to approve or reject the CTA,
it’s the science that’s important. So far on various forums discussing NSP all that the naysayer’s can come up with is the low hanging fruit…the Biologic website needing an update… not one has tried to tackle the science and doubt that any will try
:<) I admit it… I’m also on the COVID bandwagon
;<) ***** Be safe! *****
“Living in the sunshine” Always DYODD DKM